Cx Institutional Amphastar Pharmaceuticals, Inc. Transaction History
Cx Institutional
- $3.29 Billion
- Q3 2025
A detailed history of Cx Institutional transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Cx Institutional holds 63,316 shares of AMPH stock, worth $1.5 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
63,316
Previous 263,283
75.95%
Holding current value
$1.5 Million
Previous $6.05 Million
72.09%
% of portfolio
0.05%
Previous 0.21%
Shares
3 transactions
Others Institutions Holding AMPH
# of Institutions
261Shares Held
32.9MCall Options Held
18.3KPut Options Held
13K-
Black Rock Inc. New York, NY5.94MShares$141 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$63.8 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$48.3 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$38.6 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$37.4 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.16B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...